Skip to Main Content

INFORMATION FOR

Richard Antaya, MD

Professor of Dermatology; Director, Pediatric Dermatology; Medical Director, Yale Dermatology New Haven, Dermatology

Contact Information

Richard Antaya, MD

Mailing Address

  • Dermatology

    PO Box 208059, 333 Cedar Street

    New Haven, CT 06520-8059

    United States

Research Summary

Pediatric Dermatology: specializes in the diagnosis and management of all types of skin disease affecting infants, children and adolescents. Besides treating common skin disorders in children such as atopic dermatitis, psoriasis, cutaneous infections and acne, particular interests include genetic skin disorders, neonatal skin disease, medical and laser treatment of vascular malformations and hemangiomas, management dilemmas and severe skin disease affecting children of all ages.

Specialized terms: Atopic dermatitis; Infantile hemangiomas; Warts; Genetic skin diseases

Extensive Research Description

Pediatric Dermatology: specializes in the diagnosis and management of all types of skin disease affecting infants, children and adolescents. Besides treating common skin disorders in children such as atopic dermatitis, psoriasis, cutaneous infections and acne, particular interests include genetic skin disorders, neonatal skin disease, medical and laser treatment of vascular malformations and hemangiomas, management dilemmas and severe skin disease affecting children of all ages.

  • Dr. Antaya is conducting a clinical trial for adolescents who have severe atopic dermatitis using a new biologic medication.
  • Dr. Antaya is conducting a clinical trial for children who have experienced chilblains over the last 5 years.


Coauthors

Research Interests

Acne Vulgaris; Dermatitis, Atopic; Dermatology; Hemangioma; Pediatrics; Skin Diseases, Genetic; Warts; Vascular Malformations

Selected Publications

  • 399 Tralokinumab treatment modifies stratum corneum lipid composition in skin of adolescents with atopic dermatitisBerdyshev E, Simpson E, Bronova I, Pavel A, Soong W, Antaya R, Imafuku S, Røpke M, Jiang L, Guttman-Yassky E, Leung D. 399 Tralokinumab treatment modifies stratum corneum lipid composition in skin of adolescents with atopic dermatitis Journal Of Investigative Dermatology 2022, 142: s68. DOI: 10.1016/j.jid.2022.05.408.
  • 861 Intravenous gentamicin therapy for junctional epidermolysis bullosa patients harboring nonsense mutationsHao M, Antaya R, Cogan J, Hamilton C, Hou Y, Kwong A, Woodley D, Chen M. 861 Intravenous gentamicin therapy for junctional epidermolysis bullosa patients harboring nonsense mutations Journal Of Investigative Dermatology 2020, 140: s112. DOI: 10.1016/j.jid.2020.03.877.
  • Perinasal and Perioral Rash in a 2-Year-Old GirlTintle S, Antaya R, Halasz C. Perinasal and Perioral Rash in a 2-Year-Old Girl 2016, 83-87. DOI: 10.1542/9781610020176-part04-ch016.
  • Linear acral lesions in an infantMcNiff J, Kim J, Antaya R. Linear acral lesions in an infant Journal Of The American Academy Of Dermatology 2010, 63: e67-e68. DOI: 10.1016/j.jaad.2009.08.019.
  • 25 Enfermedades neoplásicas e infiltrativasProse N, Antaya R. 25 Enfermedades neoplásicas e infiltrativas 2009, 461-476. DOI: 10.1016/b978-84-8086-390-2.50025-5.
  • ColaboradoresAntaya R, Baselga E, Bernard L, Bradley J, Bree A, Bruckner A, Burkhart C, Carder K, Chan Y, Chu D, Cohen B, Cunningham B, Dinulos J, Drolet B, Enjolras O, Friedlander S, Galbraith S, Garzon M, Gibbs N, Gilliam A, Hebert A, Honig P, Howard R, Irvine A, Kim H, Kos L, Koss T, Krafchik B, Krol A, Lawley L, Levy M, Loomis C, Lucky A, Makkar H, Mancini A, Metry D, Metz B, Morrell D, Pace N, Paller A, Prendiville J, Prose N, Rogers M, Siegel D, Siegfried E, Silverman R, Tay Y, Torrelo A, Wagner A, Williams M, Wong L, Yan A. Colaboradores 2009, xi-xiii. DOI: 10.1016/b978-84-8086-390-2.50033-4.
  • PsoriasisHinds G, Antaya R. Psoriasis 2008, 2447-2454. DOI: 10.1542/9781581106411-9-ch314.
  • Chapter 25 Neoplastic and Infiltrative DiseasesProse N, Antaya R. Chapter 25 Neoplastic and Infiltrative Diseases 2008, 461-476. DOI: 10.1016/b978-1-4160-3432-2.50028-5.
  • Topical vitamin E solution versus placebo in the treatment of yellow nail syndrome: a randomized double-blind study1 1Disclosure not available at press time.Lambert E, Antaya R. Topical vitamin E solution versus placebo in the treatment of yellow nail syndrome: a randomized double-blind study1 1Disclosure not available at press time. Journal Of The American Academy Of Dermatology 2004, 50: p130. DOI: 10.1016/j.jaad.2003.10.445.